These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 15352888)

  • 1. Review article: the aetiopathogenesis of inflammatory bowel disease--immunology and repair mechanisms.
    Dignass AU; Baumgart DC; Sturm A
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():9-17. PubMed ID: 15352888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New mediators of immunity and inflammation in inflammatory bowel disease.
    Monteleone G; Fina D; Caruso R; Pallone F
    Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune mechanisms in chronic inflammatory bowel disease.
    Braegger CP; MacDonald TT
    Ann Allergy; 1994 Feb; 72(2):135-41. PubMed ID: 8109803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
    Agius LM
    J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathophysiologic rationale for biological therapies in inflammatory bowel disease.
    Gordon JN; Di Sabatino A; Macdonald TT
    Curr Opin Gastroenterol; 2005 Jul; 21(4):431-7. PubMed ID: 15930983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives.
    Neurath MF
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):81-4. PubMed ID: 10807047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.
    Mencarelli A; Renga B; Palladino G; Distrutti E; Fiorucci S
    Biochem Pharmacol; 2009 Nov; 78(9):1214-23. PubMed ID: 19555671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.
    Mankertz J; Schulzke JD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):379-83. PubMed ID: 17545772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
    Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
    Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving concepts on inflammatory bowel disease. Are we happy with the present nosology?
    Caprilli R; Viscido A
    Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):893-7. PubMed ID: 10670000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological disorders in inflammatory bowel disease and immunotherapeutic implications.
    Amati L; Caradonna L; Jirillo E; Caccavo D
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):313-25. PubMed ID: 10425578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
    Sartor RB
    Am J Gastroenterol; 1997 Dec; 92(12 Suppl):5S-11S. PubMed ID: 9395346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defensins and other antimicrobial peptides in inflammatory bowel disease.
    Wehkamp J; Schmid M; Stange EF
    Curr Opin Gastroenterol; 2007 Jul; 23(4):370-8. PubMed ID: 17545771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling for inflammation and repair in inflammatory bowel disease.
    Neuman MG
    Rom J Gastroenterol; 2004 Dec; 13(4):309-16. PubMed ID: 15624029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathogenesis of inflammatory bowel disease: current concepts.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease.
    Van Assche G; Rutgeerts P
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G169-74. PubMed ID: 15647604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammatory bowel disease: IBD].
    Endo K; Shiga H; Kinouchi Y; Shimosegawa T
    Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.